APA (7th ed.) Citation

Herbreteau, G., Vallée, A., Knol, A., Théoleyre, S., Quéreux, G., Frénard, C., . . . Denis, M. G. (2020). Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic <i>BRAF</i> or <i>NRAS</i>-Mutated Melanoma Patients. MDPI AG.

Chicago Style (17th ed.) Citation

Herbreteau, Guillaume, et al. Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic <i>BRAF</i> or <i>NRAS</i>-Mutated Melanoma Patients. MDPI AG, 2020.

MLA (8th ed.) Citation

Herbreteau, Guillaume, et al. Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic <i>BRAF</i> or <i>NRAS</i>-Mutated Melanoma Patients. MDPI AG, 2020.